BMC Cancer (Jun 2012)

MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells

  • Gregersen Lea H,
  • Jacobsen Anders,
  • Frankel Lisa B,
  • Wen Jiayu,
  • Krogh Anders,
  • Lund Anders H

DOI
https://doi.org/10.1186/1471-2407-12-232
Journal volume & issue
Vol. 12, no. 1
p. 232

Abstract

Read online

Abstract Background MicroRNAs (miRNAs) are well recognized as gene regulators and have been implicated in the regulation of development as well as human diseases. miR-143 is located at a fragile site on chromosome 5 frequently deleted in cancer, and has been reported to be down-regulated in several cancers including colon cancer. Methods To gain insight into the role of miR-143 in colon cancer, we used a microarray-based approach in combination with seed site enrichment analysis to identify miR-143 targets. Results As expected, transcripts down-regulated upon miR-143 overexpression had a significant enrichment of miR-143 seed sites in their 3'UTRs. Here we report the identification of Hexokinase 2 (HK2) as a direct target of miR-143. We show that re-introduction of miR-143 in the colon cancer cell line DLD-1 results in a decreased lactate secretion. Conclusion We have identified and validated HK2 as a miR-143 target. Furthermore, our results indicate that miR-143 mediated down-regulation of HK2 affects glucose metabolism in colon cancer cells. We hypothesize that loss of miR-143-mediated repression of HK2 can promote glucose metabolism in cancer cells, contributing to the shift towards aerobic glycolysis observed in many tumors.

Keywords